Read More Pharma Industry News Prescient Therapeutics secures FDA fast track for PTX-100 to advance CTCL treatment strategy Find out how Prescient Therapeutics’ PTX-100 just gained FDA Fast Track status, accelerating the path to treating relapsed CTCL. byPallavi MadhirajuApril 16, 2025